ADVFN Logo ADVFN
Donnée du Marché
Actualité
Outils
Donnée du Marché
Discover

Hot Features

Follow Feed

Rester connecter avec les traders et investisseurs dans notre communauté Follow Feed.

Flux des Options

Explorez des données complètes sur les options et utilisez les filtres avancés avec Options Flow.

Moniteur

Organisez et surveillez vos d'actions et actifs avec le Moniteur.
Se connecter Premium IconPremium Help Menu
CAC 40
8 006,57
0,87%
Dow Jones
38 748,86
0,10%
DAX
18 575,94
0,86%
Brent Oil
78,185
1,39%
Bitcoin
71 366,05
1,05%
Registration Strip Icon for discussion Inscrivez-vous pour interagir sur nos forums actifs pour discuter avec des investisseurs aux idées similaires.
S'inscrire
  1. Accueil
  2. Investir
  3. Actions
  4. Etats-Unis
  5. NASDAQ
  6. INVO BioScience Inc (INVO)

  7. INVO BioScience Inc (INVO) Actualités

INVO INVO BioScience Inc

0,8051
-0,0305 (-3,65%)
Dernière mise à jour : 18:36:06
Retardé de 15 minutes
Nom Action Symbole Action Marché Type
INVO BioScience Inc INVO NASDAQ Action ordinaire
  Variation Action Variation Action% Cours Dernier Dernier échange
Upgrade Icon
-0,0305 -3,65% 0,8051 18:36:06
Ouverture Plus Bas Plus Haut Prix de clôture Clôture Veille
0,86 0,8051 0,86 0,8356
plus d'informations sur les cotations »

Actualités Recentes

Date Heure Source Titre
21/5/202422:39EDGAR2Form S-3 - Registration statement under Securities Act of..
15/5/202422:51EDGAR2Form 8-K - Current report
15/5/202422:15GLOBEINVO Reports Record First Quarter 2024 Financial Results
06/5/202423:30EDGAR2Form 8-K - Current report
17/4/202416:25APSMicro Cap Massively Bid Up Before Opening Bell
16/4/202422:59GLOBEINVO Reports Fourth Quarter and Full Year 2023 Financial..
06/2/202416:24EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
01/2/202415:01EDGAR2Form 8-K - Current report
23/1/202414:00GLOBENAYA Biosciences To Acquire Clinical Stage Gene Therapy..
17/1/202414:00GLOBEINVO Bioscience Files S-4 Registration and Preliminary Joint..
16/1/202423:29EDGAR2Form S-4 - Registration of securities, business combinations
10/1/202422:46EDGAR2Form 8-K/A - Current report: [Amend]
10/1/202422:05EDGAR2Form 8-K - Current report
03/1/202423:29EDGAR2Form 8-K - Current report
28/12/202323:04EDGAR2Form 424B7 - Prospectus [Rule 424(b)(7)]
28/12/202323:02EDGAR2Form 8-K - Current report
13/12/202323:08EDGAR2Form DEFA14A - Additional definitive proxy soliciting..
13/12/202322:53EDGAR2Form 8-K - Current report
11/12/202314:00PRNUSNAYA Biosciences Announces Publication of New Data for its..
28/11/202323:18EDGAR2Form 8-K - Current report
28/11/202315:00PRNUSINVO Bioscience Regains Compliance with Nasdaq Minimum..
24/11/202319:08EDGAR2Form DEF 14A - Other definitive proxy statements
20/11/202322:59EDGAR2Form 8-K - Current report
13/11/202322:10EDGAR2Form 8-K - Current report
13/11/202322:06EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
13/11/202322:01PRNUSINVO Reports Record Third Quarter 2023 Financial Results
13/11/202315:23EDGAR2Form SC TO-C - Written communication relating to an issuer..
13/11/202315:21EDGAR2Form 8-K - Current report
13/11/202315:12EDGAR2Form PRE 14A - Other preliminary proxy statements
10/11/202315:00PRNUSNAYA Biosciences and INVO Bioscience Announce Appointment of..
09/11/202322:40PRNUSINVO Bioscience Announces Commencement of Waiver..
27/10/202315:00PRNUSFree Registration Is Now Open For Tribe Public's CEO and Q&A..
26/10/202322:56EDGAR2Form 8-K - Current report
24/10/202323:10EDGAR2Form 8-K - Current report
23/10/202313:30PRNUSINVO Bioscience and NAYA Biosciences Announce Definitive..
16/10/202312:15EDGAR2Form 8-K - Current report
11/10/202315:00PRNUSINVO to Participate in the Lytham Partners Fall 2023..
05/10/202322:28EDGAR2Form 8-K - Current report
03/10/202323:24EDGAR2Form 8-K - Current report
02/10/202323:12EDGAR2Form DEFA14A - Additional definitive proxy soliciting..
29/9/202323:26EDGAR2Form 8-K - Current report
29/9/202322:05PRNUSINVO BIOSCIENCE ANNOUNCES ADJOURNMENT OF SPECIAL MEETING OF..
28/9/202318:45EDGAR2Form DEFA14A - Additional definitive proxy soliciting..
28/9/202318:30PRNUSINVO Reminds Shareholders to Cast Their Vote for Upcoming..
08/9/202322:34EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
01/9/202323:17EDGAR2Form 8-K - Current report
01/9/202315:55EDGAR2Form DEF 14A - Other definitive proxy statements
21/8/202322:33EDGAR2Form PRE 14A - Other preliminary proxy statements
14/8/202322:10EDGAR2Form 8-K - Current report
14/8/202322:06EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]

Dernières Valeurs Consultées

NASDAQ
INVO
INVO BioScience
BIT
P1TUQ5
NLBNPIT1TUQ5 20240621 120
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

France
Société
Entreprise
Popular
Obtenir l'application
App Store
Google Play

Assistance: support@advfn.fr

En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales

© 2024 ADVFN PLC - Tous droits réservés